Interestingly, they found that supplementing HK1 in HK2-deficient cells restored overall HK activity but failed to rescue the aerobic glycolysis phenotype, strongly indicating the unique role of HK2 in GBM progression beyond that of HK1 (62). This evidence concerns the gene HK1 and glioblastoma.